Abstract
Neuropharmacological studies were carried out with reticuline, a benzylisoquinoline alkaloid, isolated from Ocotea duckei Vattimo. It was found that reticuline (50-100 mg/kg i.p.) produced alteration of behaviour pattern, prolongation of pentobarbital-induced sleep, reduction in motor coordination and D-amphetamine-induced hypermotility and suppression of the conditioned avoidance response. These observations suggest that reticuline possesses potent central nervous system depressant action.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alkaloids / administration & dosage
-
Alkaloids / pharmacology*
-
Amphetamine / pharmacology
-
Animals
-
Avoidance Learning / drug effects
-
Benzylisoquinolines*
-
Central Nervous System Depressants / administration & dosage
-
Central Nervous System Depressants / pharmacology*
-
Dopamine Antagonists / administration & dosage
-
Dopamine Antagonists / pharmacology*
-
Injections, Intraventricular
-
Isoquinolines / administration & dosage
-
Isoquinolines / pharmacology*
-
Male
-
Mice
-
Motor Activity / drug effects
-
Pentobarbital / pharmacology
-
Plant Extracts / pharmacology*
-
Plants, Medicinal / chemistry*
-
Rats
-
Rats, Wistar
-
Sleep / drug effects
Substances
-
Alkaloids
-
Benzylisoquinolines
-
Central Nervous System Depressants
-
Dopamine Antagonists
-
Isoquinolines
-
Plant Extracts
-
Amphetamine
-
Pentobarbital
-
reticuline